Rocket Lab's Dual Headwinds: Insider Selling and SpaceX IPO Overshadow Index Inclusion and NASA's $816M Contract
13.06.2026 - 18:56:00 | boerse-global.de
Rocket Lab shareholders are grappling with a paradox. The company just secured a coveted spot in the Nasdaq-100 and landed an $816 million NASA contract for 18 satellites, yet its stock suffered a brutal 11% sell-off on Friday, closing at €88.70. The conflicting signals illustrate how sector-wide shifts and internal selling are overwhelming even the most bullish corporate milestones.
The sell-off was triggered by a classic “sell the news” reaction. After initially surging 8% in pre-market trading on the index inclusion announcement, the shares reversed sharply as early buyers locked in profits. The Nasdaq-100 listing, set for June 22, forces index funds to buy Rocket Lab shares, but that passive demand was no match for the wave of profit-taking.
Compounding the pressure is the massive capital flight toward SpaceX. The 75-billion-dollar IPO from Elon Musk’s space giant is sucking liquidity out of the entire sector. Investors are rotating out of established names like Rocket Lab to get a piece of the new offering, a dynamic that has already erased a third of Rocket Lab's value since its May record high.
Should investors sell immediately? Or is it worth buying Rocket Lab?
What makes the sell-off particularly jarring is the strength of the underlying business. Rocket Lab's first-quarter revenue hit $200.3 million, a 64% jump year-over-year. The order backlog swelled to $2.2 billion, bolstered by the NASA award for 18 exploration satellites. The company now has a $69 billion market capitalization, but continues to post net losses as it pours cash into the Neutron rocket program.
Insider activity adds another layer of unease. Over the past 90 days, Rocket Lab insiders have sold roughly $67.7 million worth of shares. Director Alexander Slusky was the most notable, offloading $9 million in stock near the all-time high in late May. That kind of selling often spooks retail investors, especially when the stock is already under pressure.
Technically, the stock is hanging on by a thread. Friday’s close landed just above the 50-day moving average at €87.42. A break below that level could trigger another wave of selling. On the upside, the year-to-date gain still stands at a respectable 36%, but the volatility is unlikely to fade soon.
Operationally, all eyes are on the Neutron rocket. The company expects a first flight in the fourth quarter, while other sources point to a mid-2026 timeline. Either way, the next major catalyst for Rocket Lab will be whether it can successfully launch its medium-lift vehicle and justify its lofty valuation. Until then, the stock remains a battleground between long-term believers and short-term traders reacting to the gravitational pull of SpaceX's market debut.
Ad
Rocket Lab Stock: New Analysis - 13 June
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
